1. Dellgren G, Eriksson MJ, BlangeI , Brodin LA, Rådegran K, Sylven C. Angiotensin-converting enzyme gene polymorphism influences degree of left ventricular hypertrophy and its regression in patients undergoing operation for aortic stenosis. Am J Cardiol. 1999;84(8):909–13.
2. Youssef AA, Abd-ElWahab AM, Salama Ayyad MAK. Implications of left ventricular mass index on early postoperative outcome in patients undergoing aortic valve replacement. Egypt Heart J. 2013;65(2):131–4.
3. Cioffi G, Faggiano P, Vizzardi E, Tarantini L, Cramariuc D, Gerdts E, et al. Prognostic effect of inappropriately high left ventricular mass in asymptomatic severe aortic stenosis. Heart. 2011;97:301–7.
4. Monrad ES, Hess OM, Murakami T, Nonogi H, Corin WJ, Krayenbuehl HP. Time course of regression of left ventricular hypertrophy after aortic valve replacement. Circulation. 1988;77(6):1345–55.
5. Aymard T, Kadner A, Walpoth N, Göber V, Englberger L, Stalder M, et al. Clinical experience with the second-generation 3f Enable sutureless aortic valve prosthesis. J Thorac Cardiovasc Surg. 2010;140(2):313–6.